Cited by 115Medication Adherence and ComplianceDecision-Making and Behavioral EconomicsBehavioral Health and Interventions

Financial Reinforcers for Improving Medication Adherence: Findings from a Meta-analysis

Open access
Petry, Nancy M., Rash, Carla J., Byrne, Shannon, Ashraf, Shehryar, White, William B.·2012·The American Journal of Medicine

Abstract

Background Increasingly, financial reinforcement interventions based on behavioral economic principles are being applied in health care settings, and this study examined the use of financial reinforcers for enhancing adherence to medications.Methods Electronic databases and bibliographies of relevant references were searched, and a meta-analysis of identified trials was conducted. The variability in effect size and the impact of potential moderators (study design, duration of intervention, magnitude of reinforcement, and frequency of reinforcement) on effect size were examined.Results Fifteen randomized studies and 6 nonrandomized studies examined the efficacy of financial reinforcement interventions for medication adherence. Financial reinforcers were applied for adherence to medications for tuberculosis, substance abuse, human immunodeficiency virus, hepatitis, schizophrenia, and stroke prevention. Reinforcement interventions significantly improved adherence relative to control conditions with an overall effect size of 0.77 (95% confidence interval, 0.70-0.84; P<.001). Nonrandomized studies had a larger average effect size than randomized studies, but the effect size of randomized studies remained significant at 0.44 (95% confidence interval, 0.35-0.53; P<.001). Interventions that were longer in duration, provided an average reinforcement of $50 or more per week, and reinforced patients at least weekly resulted in larger effect sizes than those that were shorter, provided lower reinforcers, and reinforced patients less frequently.Conclusion These results demonstrate the efficacy of medication adherence interventions and underscore principles that should be considered in designing future adherence interventions. Financial reinforcement interventions hold potential for improving medication adherence and may lead to benefits for both patients and society.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjmed.2012.01.003

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Petry, N. M., Rash, C. J., Byrne, S., Ashraf, S., & White, W. B.
Affiliations
University of Connecticut (US)
Corresponding author
Petry, Nancy M.
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
2012-09
Volume
125
Issue
9
Pages
888-896
ISSN
0002-9343 (ISSN-L)
OpenAlex
W1968992146
Cited by
115
References
63
Citations by year
2026: 5 · 2025: 8 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 12 · 2020: 9 · 2019: 9 · 2018: 6 · 2017: 7 · 2016: 11 · 2015: 12 · 2014: 8 · 2013: 6 · 2012: 3
FWCI
1.18
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (P60AA003510, T32AA007290)
  • National Institute on Drug Abuse (R01DA014618, R01DA022739, R01DA021567, R01DA018883, P50DA009241, R01DA016855, P30DA023918, R01DA027615, R01DA013444, R01DA024667)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Social Sciences › Decision Sciences › General Decision Sciences › Decision-Making and Behavioral Economics
  • Social Sciences › Psychology › Applied Psychology › Behavioral Health and Interventions
Keywords
medication adherence, behavioral economics, adherence interventions, tuberculosis, substance abuse, HIV, hepatitis, schizophrenia, stroke prevention, intervention duration, reinforcement frequency, reinforcement magnitude
MeSH terms
Clinical Trials as Topic, Humans, Income, Reinforcement, Psychology, Research Design, Self Administration, United States, Randomized Controlled Trials as Topic, Drug Monitoring, Directly Observed Therapy, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review